Rankings
▼
Calendar
BHVN Q4 2023 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$948,000
Operating Income
-$154M
Net Income
-$145M
EPS (Diluted)
$-1.81
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$115M
Free Cash Flow
-$115M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$513M
Total Liabilities
$85M
Stockholders' Equity
$428M
Cash & Equivalents
$248M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$948,000
$0
—
Operating Income
-$154M
-$213M
+28.0%
Net Income
-$145M
-$201M
+28.0%
← FY 2023
All Quarters
Q1 2024 →